|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Orphan Drugs: What are the Commercializing Strategies of Marketing Leaders of Orphan Drugs in APAC |
| Authors Name: | Vedant Gaikwad , Padmashri Hirave , Dr B Lakshmi , Sai Kishore V |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_214601
|
| Published Paper Id: | IJNRD2402372 |
| Published In: | Volume 9 Issue 2, February-2024 |
| DOI: | |
| Abstract: | The Asia-Pacific (APAC) region presents a unique landscape for orphan drugs, catering to a population affected by rare diseases. This comprehensive article delves into the commercialization strategies employed by marketing leaders within this domain. Orphan drugs, designed for diseases impacting a small fraction of the population, pose distinct challenges in pricing, regulatory compliance, and market access. The article explores the prevalence of rare diseases in APAC, outlining the diverse regulatory environments across countries like Japan, Taiwan, and China. It analyzes the market size, growth projections, and key players in the pharmaceutical industry focusing on orphan medications. The article highlights the regulatory hurdles, emphasizing the complexities arising from varied standards, certification procedures, and intellectual property rights. Additionally, it underscores the need for increased awareness, streamlined regulatory frameworks, and improved access to specialized care for individuals affected by rare diseases. The article concludes by envisioning future prospects, including advancements in gene therapies and personalized medicine, that are poised to revolutionize the landscape of orphan drugs in the APAC region. |
| Keywords: | Orphan drugs APAC, rare diseases, commercializing strategies of orphan drugs, regulatory hurdles for orphan drugs, Market Landscape Rare Diseases APAC |
| Cite Article: | "Orphan Drugs: What are the Commercializing Strategies of Marketing Leaders of Orphan Drugs in APAC", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 2, page no.d691-d702, February-2024, Available :http://www.ijnrd.org/papers/IJNRD2402372.pdf |
| Downloads: | 000106 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2402372 Registration ID: 214601 Published In: Volume 9 Issue 2, February-2024 DOI (Digital Object Identifier): Page No: d691-d702 Country: Hyderabad, Telangana, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2402372 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2402372 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn